Pain in amyotrophic lateral sclerosis

scientific article published on 7 December 2016

Pain in amyotrophic lateral sclerosis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S1474-4422(16)30358-1
P698PubMed publication ID27964824

P50authorGabriele MoraQ76745763
Adriano ChiòQ30003371
P2093author name stringGiuseppe Lauria
P2860cites workAmyotrophic lateral sclerosis causes small fiber pathologyQ59698113
Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALSQ60705178
Chronic pain syndrome in amyotrophic lateral sclerosisQ71758722
Shoulder pain in amyotrophic lateral sclerosisQ83504878
Diagnosis of neuropathic pain: challenges and possibilitiesQ86352960
Amyotrophic Lateral Sclerosis Incidence and Previous Prescriptions of Drugs for the Nervous SystemQ88204204
Treatment for cramps in amyotrophic lateral sclerosis/motor neuron diseaseQ24200285
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseQ24202239
Quinine for muscle crampsQ24235626
Acupuncture for shoulder painQ24243942
Physiotherapy interventions for shoulder painQ24248777
Depressive symptoms in neurodegenerative diseasesQ26798063
Characteristics of pain in amyotrophic lateral sclerosisQ30316800
Rehabilitation in amyotrophic lateral sclerosis: why it mattersQ30407969
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progressionQ30866592
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changesQ30873214
The cerebral signature for pain perception and its modulationQ31120834
Pain in motor neuron diseaseQ33621366
Chronic pain in persons with neuromuscular diseaseQ33987789
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionQ34110857
Dyspnea-pain counterirritation induced by inspiratory threshold loading: a laser-evoked potentials studyQ34135468
Central sensitization: Implications for the diagnosis and treatment of painQ34144741
Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of needQ34182042
Cannabinoid-opioid interaction in chronic painQ34229641
Evidence for a central component of post-injury pain hypersensitivityQ34265604
Clinical practice. Chronic pruritusQ34341078
Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.Q34375695
Muscle crampsQ34419913
Neuropathic pain: redefinition and a grading system for clinical and research purposesQ34713765
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the AmQ35007618
Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosisQ35126997
Depression in amyotrophic lateral sclerosisQ35163766
Motor neurone disease: a hospice perspectiveQ35819817
The epidemiology of pain in depressionQ35892386
Pain and temperature processing in dementia: a clinical and neuroanatomical analysisQ36206029
Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre studyQ36227026
Natural history of muscle cramps in amyotrophic lateral sclerosis.Q36643076
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionQ36813236
Skin biopsy as a diagnostic tool in peripheral neuropathy.Q36959849
Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS.Q37028728
Patient-reported problematic symptoms in an ALS treatment trial.Q37164599
Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosisQ37184758
The use of integrative therapies in patients with amyotrophic lateral sclerosis in shanghai, chinaQ37398227
Drug-induced pruritus: a reviewQ37499989
Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosisQ37599038
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task forceQ37931374
Combination therapy for neuropathic pain: a review of current evidenceQ37963569
A review of experimental research on herbal compounds in amyotrophic lateral sclerosisQ38092021
Neuropathic pruritus.Q38218849
A Qualitative Study of Multidisciplinary ALS Clinic Use in the United StatesQ38617893
Physical Activity and Early Rehabilitation in Hospitalized Elderly Medical Patients: Systematic Review of Randomized Clinical Trials.Q38921269
The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis.Q39176665
Attitude of outpatients with neuromuscular diseases in Japan to pain and use of analgesicsQ39329403
Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain reliefQ39329951
Survey of cannabis use in patients with amyotrophic lateral sclerosisQ39382412
Pain in amyotrophic lateral sclerosis: a population-based controlled study.Q39700757
ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherinQ39974165
The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral SclerosisQ39977770
Pain in amyotrophic lateral sclerosis: Patient and physician perspectives and practices.Q40380353
Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and WashingtonQ40618574
Depression in ALS in a large self-reporting cohortQ40903244
18F-FDG-PET correlates of cognitive impairment in ALS.Q41108738
The quality of care and symptom control--the effects on the terminal phase of ALS/MND.Q41194833
Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study.Q41487079
Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?Q42765711
Pain in amyotrophic lateral sclerosis: a neglected aspect of diseaseQ42797616
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.Q43055391
Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.Q43075467
Depression in chronic pain patients: prevalence and measurementQ43456944
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisQ43569621
Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers.Q43777133
The last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative studyQ44033907
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based studyQ44591084
Prevalence and characteristics of pain in early and late stages of ALS.Q44705987
Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron diseaseQ46343764
Osteopathic Manual Treatment for Amyotrophic Lateral Sclerosis: A Feasibility Pilot Study.Q47168226
Disparities in perceptions of distress and burden in ALS patients and family caregivers.Q47337859
Correlates of suffering in amyotrophic lateral sclerosisQ47348801
Ventilator dependence and expressions of need: a study of patients with amyotrophic lateral sclerosis in JapanQ47607921
Iyengar yoga therapy as an intervention for cramp management in individuals with amyotrophic lateral sclerosis: three case reportsQ48127165
Dyspnea as a noxious sensation: inspiratory threshold loading may trigger diffuse noxious inhibitory controls in humansQ48461885
Sporadic motor neuron disease with severe sensory neuronopathyQ48483957
Pain in Amyotrophic Lateral Sclerosis: a psychological perspectiveQ48515636
Absence of SOD1 gene abnormalities in familial amyotrophic lateral sclerosis with posterior column involvement without Lewy-body-like hyaline inclusionsQ48879026
Structural brain correlates of cognitive and behavioral impairment in MND.Q48934859
Involvement of distal sensory nerves in amyotrophic lateral sclerosis.Q50661254
Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients.Q50707459
Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input.Q51430960
Neurologic disease at the end of life: caregiver descriptions of Parkinson disease and amyotrophic lateral sclerosis.Q51891176
Clinical indicators of 'nociceptive', 'peripheral neuropathic' and 'central' mechanisms of musculoskeletal pain. A Delphi survey of expert clinicians.Q53059559
What are we doing to waiting list controls?Q53415465
Subjective experience and coping in ALSQ54738846
Amyotrophic lateral sclerosisQ55877676
Cramps, muscle pain, and fasciculations: not always benign?Q56929777
Small-fiber neuropathy in patients with ALSQ57232614
Reassessing received wisdom in ALS - pain is common when studied systematicallyQ57357887
Amyotrophic lateral sclerosis: clinical analysis of 78 cases from Fortaleza (Northeastern Brazil)Q57450699
7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosisQ57592495
Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European surveyQ58188222
The evaluation of pain in amyotrophic lateral sclerosis: A case controlled observational studyQ58293600
The value of muscle exercise in patients with amyotrophic lateral sclerosisQ59416877
P433issue2
P921main subjectamyotrophic lateral sclerosisQ206901
P304page(s)144-157
P577publication date2016-12-07
P1433published inLancet NeurologyQ15755067
P1476titlePain in amyotrophic lateral sclerosis
P478volume16

Reverse relations

cites work (P2860)
Q56531747Amyotrophic lateral sclerosis
Q47790158Beyond weakness: Characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: A controlled study.
Q90702960Brain Abscess Presenting as Prolonged Headache in a Patient with Amyotrophic Lateral Sclerosis under Mechanical Ventilation
Q48153881Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy
Q98281049No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study
Q92489514Physical therapy for individuals with amyotrophic lateral sclerosis: current insights
Q93185685Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives
Q92697340Tapentadol for neuropathic pain: a review of clinical studies